Skip to main content
. 2022 Feb 22;11(5):1170. doi: 10.3390/jcm11051170

Table 2.

Medication at the time of inclusion at the baseline visit.

Medication %
Diuretics 76.3
Ivabradine 12.9
Digital 7.1
Statins 70.8
SGLT2i 18.1
Antiplatelet 40.0
Anticoagulants 48.5
Amiodarone 11.7
Nitrates 6.2

Notes: Specific drugs for the treatment of heart failure and reduced ejection fraction (HFrEF) are not included. Results are expressed in % (n = 565). SGLT2i, Sodium/glucose cotransporter-2 inhibitors.